Selective targeting of epigenetic reader domains. - Test2 - elhamkhani - TriplyDB

Selective targeting of epigenetic reader domains.

Selective targeting of epigenetic reader domains.

http://www.wikidata.org/entity/Q38748150

about

Chemical modulators for epigenome reader domains as emerging epigenetic therapies for cancer and inflammation.Computer-Aided Drug Design in Epigenetics.Chromatin Regulation by HP1γ Contributes to Survival of 5-Azacytidine-Resistant Cells

P2860

Q39423291-BDE7AA20-5748-4933-A068-DE33375910B4 Q55120002-6F60F112-7202-4F0A-B82F-BCA222C6BB05 Q58554160-04109F30-B5F0-431B-B24B-8F6878A6425A

P2860

Selective targeting of epigenetic reader domains.

http://www.wikidata.org/entity/Q38748150

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Selective targeting of epigenetic reader domains.

@en

type

label

Selective targeting of epigenetic reader domains.

@en

prefLabel

Selective targeting of epigenetic reader domains.

@en

P1433

Q38748150-CA239254-9BB7-4783-816A-E73111A8BE80

P1476

Q38748150-47450515-3146-408A-8CAF-D9929615A437

P2093

Q38748150-5BE4037C-5EED-4F6D-BC01-C0E5F16A863B

Q38748150-9D38CA46-298C-44ED-BDDE-4AD9806DF385

Q38748150-E535AB95-CE8A-47FC-839C-80B717A9E34F

P2860

Q38748150-0005EAFD-1023-4D11-B167-64F5C2AD39EB

Q38748150-04723A6B-62AA-4B25-AB4D-C13BE46CE582

Q38748150-048BA430-59A9-4FE5-ACE8-2C260555C51A

Q38748150-050AA13C-7ADE-4E72-9BB8-699C325387FC

Q38748150-08E1180A-5EFC-4A6A-9DE6-FA49DBB55E83

Q38748150-0E237E5F-FAC1-4993-A610-4A3A6F352C8F

Q38748150-0F5E3301-2A93-4085-98BF-219C11DFB49D

Q38748150-10E0F22F-A12F-46C4-8236-0988A7EBE7FB

Q38748150-13CC11F7-2E8A-4A51-AF46-8D17AF058584

Q38748150-1B89C802-124E-4A82-87A7-72BFC9BFBEF6

P304

Q38748150-C4C33C22-2A6C-434C-9525-A7C0EC04EB39

P31

Q38748150-4E0C7150-85E1-429A-86C4-DF3E5AC2D21A

P356

Q38748150-D00F3A04-7314-467E-A386-0FF52080339D

P407

Q38748150-FD0C9991-815E-40AD-AAB3-C9C2DA840EBF

P433

Q38748150-0BFC9F0A-A307-49D5-9F92-DFB1A38C357A

P478

Q38748150-B3A2EF07-C15D-408E-88D7-BBFAC0610DB3

P577

Q38748150-CACA3E7B-09C7-4BBF-9755-B0C1C42739EC

P698

Q38748150-901314A7-8562-47FA-A544-B55EBB9A3685

P356

17460441.2017.1303474

P1433

Expert Opinion on Drug Discovery

P1476

Selective targeting of epigenetic reader domains.

@en

P2093

Holger Greschik

http://www.w3.org/2001/XMLSchema#string

Roland Schüle

http://www.w3.org/2001/XMLSchema#string

Thomas Günther

http://www.w3.org/2001/XMLSchema#string

P2860

Selective inhibition of BET bromodomains

Distinct mode of methylated lysine-4 of histone H3 recognition by tandem tudor-like domains of Spindlin1

Histone recognition and large-scale structural analysis of the human bromodomain family

Molecular basis underlying histone H3 lysine-arginine methylation pattern readout by Spin/Ssty repeats of Spindlin1

Mechanism and regulation of acetylated histone binding by the tandem PHD finger of DPF3b

Small-molecule inhibition of BRDT for male contraception.

Chemical genetics approaches for selective intervention in epigenetics

Epigenetic modulators, modifiers and mediators in cancer aetiology and progression

Open access chemical probes for epigenetic targets

The interplay of histone modifications - writers that read

P304

449-463

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17460441.2017.1303474

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28277835

http://www.w3.org/2001/XMLSchema#string